Cargando…
Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC
Background: Triple-negative breast cancer (TNBC) is not sensitive to targeted therapy with HER-2 monoclonal antibody and endocrine therapy due to lack of ER, PR, and HER-2 receptors. TNBC is a breast cancer subtype with the worst prognosis and the highest mortality rate compared with other subtypes....
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586457/ https://www.ncbi.nlm.nih.gov/pubmed/34777466 http://dx.doi.org/10.3389/fgene.2021.730442 |